HU170643B - - Google Patents
Info
- Publication number
- HU170643B HU170643B HUSC510A HUSC000510A HU170643B HU 170643 B HU170643 B HU 170643B HU SC510 A HUSC510 A HU SC510A HU SC000510 A HUSC000510 A HU SC000510A HU 170643 B HU170643 B HU 170643B
- Authority
- HU
- Hungary
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
- C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
- C07J1/0029—Ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
- C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
- C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
- C07J1/0025—Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
- C07J1/0037—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
- C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
- C07J1/0048—Alkynyl derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/002—Carbocyclic rings fused
- C07J53/004—3 membered carbocyclic rings
- C07J53/005—3 membered carbocyclic rings in position 12
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2410443A DE2410443A1 (de) | 1974-03-01 | 1974-03-01 | 11beta-fluor-androstene |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HU170643B true HU170643B (cg-RX-API-DMAC10.html) | 1977-07-28 |
Family
ID=5909131
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUSC510A HU170643B (cg-RX-API-DMAC10.html) | 1974-03-01 | 1975-02-28 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US3966713A (cg-RX-API-DMAC10.html) |
| JP (1) | JPS50121259A (cg-RX-API-DMAC10.html) |
| BE (1) | BE826139A (cg-RX-API-DMAC10.html) |
| CA (1) | CA1037024A (cg-RX-API-DMAC10.html) |
| CS (1) | CS181779B2 (cg-RX-API-DMAC10.html) |
| DD (1) | DD118623A5 (cg-RX-API-DMAC10.html) |
| DE (1) | DE2410443A1 (cg-RX-API-DMAC10.html) |
| DK (1) | DK137539C (cg-RX-API-DMAC10.html) |
| ES (1) | ES435204A1 (cg-RX-API-DMAC10.html) |
| FR (1) | FR2262528B1 (cg-RX-API-DMAC10.html) |
| GB (1) | GB1504410A (cg-RX-API-DMAC10.html) |
| HU (1) | HU170643B (cg-RX-API-DMAC10.html) |
| IL (1) | IL46712A0 (cg-RX-API-DMAC10.html) |
| NL (1) | NL7502445A (cg-RX-API-DMAC10.html) |
| SE (1) | SE7502239L (cg-RX-API-DMAC10.html) |
| SU (1) | SU656529A3 (cg-RX-API-DMAC10.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4943579A (en) * | 1987-10-06 | 1990-07-24 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Water soluble prodrugs of camptothecin |
| IL146284A0 (en) | 1999-05-04 | 2002-07-25 | Strakan Ltd | Androgen glycosides and pharmaceutical compositions containing the same |
| DE10104327A1 (de) | 2001-01-24 | 2002-07-25 | Schering Ag | 11beta-Halogensteroide, deren Herstellung und Verwendung zur Herstellung von Arzneimitteln sowie 11beta-Halogensteroide enthaltende pharmazeutische Präparate |
| WO2009111574A2 (en) * | 2008-03-05 | 2009-09-11 | Evestra, Inc. | BISMETHYLENE-17α CARBOLACTONES AND RELATED USES |
| US8222237B2 (en) * | 2008-11-25 | 2012-07-17 | Evestra, Inc. | Progestational 3-(6,6-ethylene-17B-hydroxy-3-oxo-17A-pregna-4-ene-17A-yl)propionic acid G-lactones |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3056807A (en) * | 1961-10-09 | 1962-10-02 | Upjohn Co | Process for the preparation of fluorosteroids |
| US3875148A (en) * | 1971-07-09 | 1975-04-01 | Glaxo Lab Ltd | 9{60 -unsubstituted-11{62 -bromo-19-norsteroids |
| US3767685A (en) * | 1972-02-02 | 1973-10-23 | Akzona Inc | Novel 11beta-halo-steroids of the oestrane series |
-
1974
- 1974-03-01 DE DE2410443A patent/DE2410443A1/de not_active Ceased
-
1975
- 1975-02-25 CS CS7500001236A patent/CS181779B2/cs unknown
- 1975-02-25 US US05/552,958 patent/US3966713A/en not_active Expired - Lifetime
- 1975-02-26 SU SU752108355A patent/SU656529A3/ru active
- 1975-02-27 SE SE7502239A patent/SE7502239L/xx unknown
- 1975-02-27 IL IL46712A patent/IL46712A0/xx unknown
- 1975-02-27 DK DK78775A patent/DK137539C/da active
- 1975-02-27 DD DD184464A patent/DD118623A5/xx unknown
- 1975-02-28 BE BE153876A patent/BE826139A/xx unknown
- 1975-02-28 JP JP50024935A patent/JPS50121259A/ja active Pending
- 1975-02-28 HU HUSC510A patent/HU170643B/hu unknown
- 1975-02-28 ES ES435204A patent/ES435204A1/es not_active Expired
- 1975-02-28 NL NL7502445A patent/NL7502445A/xx not_active Application Discontinuation
- 1975-03-03 FR FR7506531A patent/FR2262528B1/fr not_active Expired
- 1975-03-03 CA CA222,174A patent/CA1037024A/en not_active Expired
- 1975-03-03 GB GB8742/75A patent/GB1504410A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| NL7502445A (nl) | 1975-09-03 |
| DK137539B (da) | 1978-03-20 |
| FR2262528A1 (cg-RX-API-DMAC10.html) | 1975-09-26 |
| DK137539C (da) | 1978-09-04 |
| CA1037024A (en) | 1978-08-22 |
| US3966713A (en) | 1976-06-29 |
| IL46712A0 (en) | 1975-04-25 |
| DD118623A5 (cg-RX-API-DMAC10.html) | 1976-03-12 |
| DE2410443A1 (de) | 1975-09-11 |
| GB1504410A (en) | 1978-03-22 |
| DK78775A (cg-RX-API-DMAC10.html) | 1975-11-03 |
| SE7502239L (cg-RX-API-DMAC10.html) | 1975-09-02 |
| AU7855175A (en) | 1976-08-26 |
| ES435204A1 (es) | 1976-12-16 |
| CS181779B2 (en) | 1978-03-31 |
| SU656529A3 (ru) | 1979-04-05 |
| FR2262528B1 (cg-RX-API-DMAC10.html) | 1978-06-30 |
| JPS50121259A (cg-RX-API-DMAC10.html) | 1975-09-23 |
| BE826139A (fr) | 1975-08-28 |